These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16415943)

  • 1. [Hyperprolactinemia induced by antipsychotic agents].
    Johnsen E; Jørgensen HA
    Tidsskr Nor Laegeforen; 2006 Jan; 126(2):179-80. PubMed ID: 16415943
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotic-induced hyperprolactinemia.
    Bostwick JR; Guthrie SK; Ellingrod VL
    Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Management of Antipsychotic-Induced Hyperprolactinemia.
    Wong-Anuchit C
    Perspect Psychiatr Care; 2016 Apr; 52(2):145-52. PubMed ID: 25772527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
    Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
    J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprolactinaemia caused by antipsychotic drugs: a new application for prolactin assays.
    Ellis A; Fahie-Wilson M
    Ann Clin Biochem; 2010 Jul; 47(Pt 4):287-9. PubMed ID: 20592330
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia.
    Poyraz BC; Aksoy C; Balcioğlu I
    Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on Hyperprolactinaemia and antipsychotic therapy in schizophrenia.
    Howes OD; Smith S; Aitchison KJ
    Curr Med Res Opin; 2004 Oct; 20(10):1649. PubMed ID: 15462698
    [No Abstract]   [Full Text] [Related]  

  • 8. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
    Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU
    Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
    Byerly M; Suppes T; Tran QV; Baker RA
    J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
    Paparrigopoulos T; Liappas J; Tzavellas E; Mourikis I; Soldatos C
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):92-6. PubMed ID: 16938372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic-induced hyperprolactinemia and delusion of pregnancy.
    Ahuja N; Moorhead S; Lloyd AJ; Cole AJ
    Psychosomatics; 2008; 49(2):163-7. PubMed ID: 18354070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antipsychotic-induced symptomatic hyperprolactinemia: clinical consequences and therapeutic strategies].
    Pollice R; Di Giovambattista E; Tomassini A; Di Pucchio A; Ussorio D; Roncone R; Casacchia M
    Clin Ter; 2007; 158(2):173-9. PubMed ID: 17566521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drug-induced hyperprolactinemia: clinical implications.
    Molitch ME
    Endocr Pract; 2000; 6(6):479-81. PubMed ID: 11155224
    [No Abstract]   [Full Text] [Related]  

  • 14. Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride.
    Kopecek M; Bares M; Horácek J
    Neuro Endocrinol Lett; 2005 Aug; 26(4):320. PubMed ID: 16136015
    [No Abstract]   [Full Text] [Related]  

  • 15. The disparity of pharmacokinetics and prolactin study for risperidone long-acting injection.
    Peng PW; Huang MC; Tsai CJ; Pan CH; Chen CC; Chiu CC
    J Clin Psychopharmacol; 2008 Dec; 28(6):726-7; author reply 727-8. PubMed ID: 19011459
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.
    Akkaya C; Kaya B; Kotan Z; Sarandol A; Ersoy C; Kirli S
    J Psychopharmacol; 2009 Aug; 23(6):723-6. PubMed ID: 18562408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia.
    Kopecek M; Bares M; Horacek J; Mohr P
    Neuro Endocrinol Lett; 2006 Dec; 27(6):803-6. PubMed ID: 17187006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
    Lai YC; Chiou CC; Chen CH; Huang MC
    J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693
    [No Abstract]   [Full Text] [Related]  

  • 20. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
    Holzer L; Eap CB
    J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.